<DOC>
	<DOCNO>NCT00546637</DOCNO>
	<brief_summary>To evaluate efficacy safety fesoterodine overactive bladder symptom improvement add ongoing alpha blocker treatment .</brief_summary>
	<brief_title>Fesoterodine `` add-on '' Male Overactive Bladder Study</brief_title>
	<detailed_description />
	<mesh_term>Urinary Bladder , Overactive</mesh_term>
	<mesh_term>Lower Urinary Tract Symptoms</mesh_term>
	<mesh_term>Fesoterodine</mesh_term>
	<criteria>Men age 40 year . On stable welltolerated dose alphablocker prescribe LUTS least 6 week prior screen ( Visit 1 ) . Persistent symptom OAB urinary frequency &gt; =8 times/24 hour micturitionrelated urgency episode &gt; =3 episode/24 hour . Contraindication fesoterodine ( antimuscarinics ) . Previous history acute urinary retention require catheterization severe void difficulty judgment investigator , prior baseline . Unable follow study procedure , include completion selfadministered bladder diary patient report outcome questionnaire .</criteria>
	<gender>Male</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2011</verification_date>
</DOC>